Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) — Net Asset Quality Index
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Net Asset Quality Index of 85.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥18.38 Billion minus total liabilities of CN¥2.63 Billion yields net assets of CN¥15.76 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Zhangzhou Pientzehuang Pharmaceutical Co defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2000–2025)
This chart shows how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of March 2026, the index stands at 85.7%, representing net assets of CN¥15.76 Billion against total assets of CN¥18.38 Billion CNY. Explore Zhangzhou Pientzehuang Pharmaceutical Co (600436) cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2000–2025)
The table below presents the year-by-year Net Asset Quality Index for Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Zhangzhou Pientzehuang Pharmaceutical Co market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 85.9% | CN¥15.09 Billion | CN¥17.56 Billion | CN¥2.47 Billion | ▲ +1.3 pp |
| 2024 | 84.6% | CN¥14.84 Billion | CN¥17.54 Billion | CN¥2.70 Billion | ▲ +3.1 pp |
| 2023 | 81.5% | CN¥13.92 Billion | CN¥17.08 Billion | CN¥3.16 Billion | ▲ +0.5 pp |
| 2022 | 81.0% | CN¥11.82 Billion | CN¥14.60 Billion | CN¥2.78 Billion | ▼ -0.2 pp |
| 2021 | 81.1% | CN¥10.14 Billion | CN¥12.50 Billion | CN¥2.36 Billion | ▲ +0.2 pp |
| 2020 | 80.9% | CN¥8.26 Billion | CN¥10.21 Billion | CN¥1.95 Billion | ▲ +1.8 pp |
| 2019 | 79.1% | CN¥6.97 Billion | CN¥8.81 Billion | CN¥1.84 Billion | ▼ -0.6 pp |
| 2018 | 79.7% | CN¥5.31 Billion | CN¥6.66 Billion | CN¥1.35 Billion | ▲ +1.4 pp |
| 2017 | 78.3% | CN¥4.43 Billion | CN¥5.65 Billion | CN¥1.22 Billion | ▲ +3.9 pp |
| 2016 | 74.5% | CN¥3.75 Billion | CN¥5.04 Billion | CN¥1.29 Billion | ▼ -7.0 pp |
| 2015 | 81.5% | CN¥3.30 Billion | CN¥4.05 Billion | CN¥751.60 Million | ▼ -0.4 pp |
| 2014 | 81.9% | CN¥2.99 Billion | CN¥3.65 Billion | CN¥662.34 Million | ▲ +2.3 pp |
| 2013 | 79.5% | CN¥2.59 Billion | CN¥3.26 Billion | CN¥667.05 Million | ▲ +9.8 pp |
| 2012 | 69.7% | CN¥1.56 Billion | CN¥2.23 Billion | CN¥675.22 Million | ▼ -6.1 pp |
| 2011 | 75.8% | CN¥1.19 Billion | CN¥1.57 Billion | CN¥379.69 Million | ▲ +0.9 pp |
| 2010 | 74.9% | CN¥1.08 Billion | CN¥1.45 Billion | CN¥362.97 Million | ▲ +8.2 pp |
| 2009 | 66.7% | CN¥857.19 Million | CN¥1.28 Billion | CN¥427.35 Million | ▼ -3.5 pp |
| 2008 | 70.3% | CN¥752.09 Million | CN¥1.07 Billion | CN¥318.45 Million | ▼ -7.9 pp |
| 2007 | 78.2% | CN¥758.85 Million | CN¥970.88 Million | CN¥212.03 Million | ▼ -6.8 pp |
| 2006 | 85.0% | CN¥621.09 Million | CN¥730.62 Million | CN¥109.53 Million | ▼ -2.7 pp |
| 2005 | 87.7% | CN¥608.07 Million | CN¥693.63 Million | CN¥85.56 Million | ▼ -8.8 pp |
| 2004 | 96.5% | CN¥539.08 Million | CN¥558.77 Million | CN¥19.69 Million | ▲ +3.4 pp |
| 2003 | 93.0% | CN¥553.59 Million | CN¥594.99 Million | CN¥41.40 Million | ▲ +45.5 pp |
| 2002 | 47.5% | CN¥154.81 Million | CN¥325.79 Million | CN¥170.99 Million | ▼ -6.5 pp |
| 2001 | 54.0% | CN¥146.02 Million | CN¥270.36 Million | CN¥124.34 Million | ▼ -0.6 pp |
| 2000 | 54.6% | CN¥141.35 Million | CN¥258.68 Million | CN¥117.33 Million | — |